Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Oct 30, 2025 · Ragosa Mark sold 100 shares at $41.00/share ($4,100); exercised options for 100 shares

Ragosa Mark sold 100 shares at $41.00/share ($4,100); exercised options for 100 shares

xslF345X05/form4-10302025_081002.xml

xslF345X05/form4-10302025_081002.xmlSEC.gov

ex24-10302025_081002.htm

ex24-10302025_081002.htmSEC.gov

Graphics and non-inline formats (not embedded below).